Ionis Pharmaceuticals Inc... (IONS)
Ionis Pharmaceuticals Statistics
Share Statistics
Ionis Pharmaceuticals has 159.16M shares outstanding. The number of shares has increased by 8.91% in one year.
| 159.16M |
| 8.91% |
| 0.68% |
| 99.99% |
| n/a |
| 42 |
| n/a |
Short Selling Information
The latest short interest is 15.27M, so 9.6% of the outstanding shares have been sold short.
| 15.27M |
| 9.6% |
| 11.2% |
| 9.36 |
Valuation Ratios
The PE ratio is -11.52 and the forward PE ratio is -11.33. Ionis Pharmaceuticals's PEG ratio is -0.61.
| -11.52 |
| -11.33 |
| 7.41 |
| 2.5 |
| 8.88 |
| -9.57 |
| -0.61 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Ionis Pharmaceuticals.
| n/a |
| n/a |
| n/a |
| n/a |
Financial Position
The company has a current ratio of 8.47, with a Debt / Equity ratio of 2.41.
| 8.47 |
| 8.43 |
| 2.41 |
| -2.98 |
| -2.59 |
| -5.25 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| n/a |
| n/a |
| n/a |
| $659,623.95 |
| $-424,599.63 |
| 1,069 |
| 0.23 |
| 0.9 |
Taxes
| -6.17M |
| 1.34% |
Stock Price Statistics
The stock price has increased by -11.34% in the last 52 weeks. The beta is 0.18, so Ionis Pharmaceuticals's price volatility has been higher than the market average.
| 0.18 |
| -11.34% |
| 31.04 |
| 35.7 |
| 64.39 |
| 1,670,436 |
Income Statement
In the last 12 months, Ionis Pharmaceuticals had revenue of 705.14M and earned -453.9M in profits. Earnings per share was -3.04.
| 705.14M |
| 693.92M |
| -475.08M |
| -453.9M |
| -475.08M |
| -477.06M |
| -3.04 |
Balance Sheet
The company has 242.08M in cash and 1.42B in debt, giving a net cash position of -1.17B.
| 242.08M |
| 1.42B |
| -1.17B |
| -2.25B |
| 2.81B |
| 2.17B |
Cash Flow
In the last 12 months, operating cash flow was -500.95M and capital expenditures -45.28M, giving a free cash flow of -546.23M.
| -500.95M |
| -45.28M |
| -546.23M |
| -3.65 |
Margins
Gross margin is 98.41%, with operating and profit margins of -67.37% and -64.37%.
| 98.41% |
| -67.37% |
| -65.25% |
| -64.37% |
| -67.37% |
| -67.37% |
| -77.46% |
Dividends & Yields
IONS does not appear to pay any dividends at this time.
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
Analyst Forecast
The average price target for IONS is $59, which is 66.9% higher than the current price. The consensus rating is "Buy".
| $59 |
| 66.9% |
| Buy |
| 18 |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| n/a |
| n/a |
| n/a |
| n/a |
Scores
| 0.82 |
| 3 |